Search hospitals > California > Carmichael
Mercy Cancer Center �� Carmichael
Claim this profileCarmichael, California 95608
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Prostate Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
72 reported clinical trials
2 medical researchers
Summary
Mercy Cancer Center �� Carmichael is a medical facility located in Carmichael, California. This center is recognized for care of Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. Mercy Cancer Center �� Carmichael is involved with conducting 72 clinical trials across 221 conditions. There are 2 research doctors associated with this hospital, such as Shahzad Siddique and Matthew D. Wheatley.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 positive
ER positive
Top PIs
Shahzad SiddiquePenrose-Saint Francis Healthcare4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
111 reported clinical trials
176 drugs studied
Matthew D. WheatleyMercy Cancer Center �� Carmichael3 years of reported clinical research
Studies Breast Cancer
Studies Recurrence
1 reported clinical trial
5 drugs studied
Clinical Trials running at Mercy Cancer Center �� Carmichael
Breast Cancer
Cancer
Non-Small Cell Lung Cancer
Gastric Cancer
Multiple Myeloma
Prostate Cancer
Lung Cancer
Rectal Cancer
Esophageal Cancer
Squamous Cell Carcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Mercy Cancer Center �� Carmichael?
Mercy Cancer Center �� Carmichael is a medical facility located in Carmichael, California. This center is recognized for care of Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. Mercy Cancer Center �� Carmichael is involved with conducting 72 clinical trials across 221 conditions. There are 2 research doctors associated with this hospital, such as Shahzad Siddique and Matthew D. Wheatley.